Clinical Trial

Outcomes of Sepsis Patients in China (CHINA-SEP)

Study acronym: CHINA-SEP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Sepsis poses a significant public health challenge in China. However, longitudinal real-world evidence on guideline adherence and patient outcomes remains scarce. This registry aims to address these gaps by systematically capturing guideline-concordant treatment patterns and associated outcomes in ICU patients diagnosed according to Sepsis-3.0 criteria across diverse settings, thereby generating actionable evidence to improve the quality of sepsis care nationwide.
Trial Details
NCT Number NCT07066553
Lead Sponsor Southeast University, China
Conditions Sepsis
Enrollment 5,775 participants
Start Date 2025-07-18
Primary Completion 2026-09 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-15